Trial Profile
Comparing Deep Neuromuscular Block and Moderate Neuromuscular Block in Patients Undergoing Laparoscopic Gynaecological Surgeries: Impact on Surgical Satisfaction of Operating Conditions and Patient Satisfaction
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 13 May 2022
Price :
$35
*
At a glance
- Drugs Rocuronium bromide (Primary)
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- 02 Oct 2018 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 25 Jun 2016 New trial record